期刊文献+

Logistic回归和ROC曲线分析多种肿瘤标志物在肝癌诊断中的应用 被引量:6

Assessment of diagnostic value of various tumors markers for primary hepatic carcinoma with logistic regression and ROC curve
暂未订购
导出
摘要 目的应用Logistic回归和ROC曲线分析肿瘤标志物在肝癌中的诊断。方法收集原发性肝癌63例,良性肝病58例,正常对照76例,用ABBOTT AXSYM化学发光分析仪测定CEA、AFP、CA125和CA199,绘制ROC曲线并计算曲线下面积(AUC)评价各指标的诊断价值。结果肝癌-正常对照组,4项联合诊断肝癌的AUC(0.973)高于各单项检查的AUC(P<0.05);肝癌-肝病组,CA125被剔除(P=0.28),CEA、AFP、CA199入选回归方程,CEA、AFP、CA199联检的AUC(0.909)高于AFP的AUC(0.814)(P<0.05),2组AFP的AUC均高于其他各单项的AUC(P<0.05)。结论 AFP在原发性肝癌的诊断中有较好的应用价值,AFP、CEA、CA199联检可提高诊断效能,为判别良、恶性肝病提供参考,而CA125在判定肝病良、恶性时价值不大。 Objective To explore the diagnostic value of CEA,AFP, CA125,CA199 and the combined examination of them for pri- mary hepatic carcinoma(PHC) with a model of logistic regression and ROC curve. Methods Serum CEA,AFP,CA125 and CA199 levels were measured with ABBOTT AXSYM in 63 cases with PHC ,58 cases with benign disease of liver and 76 normal control cases . Applied lo- gistic regression, plotted ROC curve and calculated the area under ROC curve (AUC) to assess the diagnostic value of each index. Results In PHC - control group, the AUC of combination of CEA, AFP, CA125, CA199 was larger than any AUC of them alone(P 〈 O. 05). In PHC - benign disease of liver group, Logistic regression excluding CA125 (P = 0.28), AFP, CEA and CA199 were selected into Logistic regres- sion equation, the AUC (0. 909) of combination of CEA, AFP and CA199 was larger than the AUC (0.814) of AFP( P 〈 0.05), the AUC of AFP was larger than single index in both two groups (P 〈 0.05). Conclusion AFP has a higher value in the diagnosis of PHC, the com- bined examination of AFP,CEA and CA199 for PHC is superior to any single index examination and it can give more information for differen- tial diagnosis, while CA125 is less helpful.
出处 《安徽医学》 2012年第7期894-896,共3页 Anhui Medical Journal
关键词 原发性肝癌 肿瘤标志物 ROC曲线 Primary liver carcinoma Tumor markers ROC curve
  • 相关文献

参考文献9

二级参考文献43

  • 1吴健民.对肿瘤标志物的再认识[J].中华检验医学杂志,2005,28(1):11-13. 被引量:116
  • 2Charlotte E Ariyan,Ronald R Salem.Evolution in the treatment of metastatic colorectal carcinoma of the liver[J].World Journal of Gastroenterology,2006,12(20):3253-3258. 被引量:9
  • 3童红莉,田亚平.血清CA125临床意义的回顾性分析[J].现代肿瘤医学,2006,14(12):1603-1604. 被引量:17
  • 4王亚婷,李丽,张静,郭芳.AFP、CA19-9联合检测原发性肝癌的对比观察[J].中国误诊学杂志,2007,7(1):35-36. 被引量:2
  • 5连利娟,林巧雅.妇科肿瘤学.4版.北京:人民卫生出版社,2006:410-413.
  • 6Abelev GI. Production of embryonal serum alpha - globulin by hepatomas: review of experimental and clinical data. Cancer Res, 1968, 28(10) : 1344 - 1350.
  • 7Malaguarnera G, Giordano M, Paladina I, et al. Serum markers of hepatocellular carcinoma. Dig Dis Sci, 2010, 55 (10) :2744 -55.
  • 8Mohammed MS, Elshemey WM, Hussein TD, et al. En- hanced detection of hepatocellular carcinoma. Cancer Con- trol, 2005, 12(4) :248 -253.
  • 9Whitehouse C, Solomon E. Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening. Gynecol Oncol 2003;88(1 Pt 2):S152-157
  • 10Guppy AE, Rustin GJ. CA125 response: can it replace the traditional response criteria in ovarian cancer? Oncologist 2002;7:437-443

共引文献92

同被引文献52

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部